|
|
|
|
|
by jlbooker
1599 days ago
|
|
The trials lasted long enough to gather the statistical evidence needed to show that the vaccine prevented the trial group from becoming infected (and that it was highly unlikely the trial group did better due to random chance). When that point was reached, the trial was deemed sufficient and was ended/unblinded. When people are dying by the thousands every day (in the USA alone), how much longer would you have wanted the trial to go on? We found out what we wanted to know. The vaccine worked. There's no need to carry on and ask the placebo group to continue with the risk of being infected. |
|
Remember, the people defending Ivermectin also argue that it's unethical to do further trials when it is "clearly effective" (according to under-powered studies). Consider that pharma companies deliberately avoid follow-up trials to avoid finding results that don't align with business interest. Remdesivir and Molnupiravir both looked promising in early trials, but were found to be rather ineffective (and dangerous) in later trials.
I don't have a problem with administering drugs/vaccines based on good faith and speculative benefit if that is declared appropriately. Just don't dress it up as "scientifically validated".